CHLORAPREP TRIPLE SWABSTICK
LOE Approachingchlorhexidine gluconate and isopropyl alcohol
NDATOPICALSWAB
Approved
Oct 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CHLORAPREP TRIPLE SWABSTICK (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2002.
Drug data last refreshed 48m ago · AI intelligence enriched 6h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLORAPREP TRIPLE SWABSTICK is a topical antiseptic swab combining chlorhexidine gluconate and isopropyl alcohol for skin preparation before medical procedures. It works by rapidly killing bacteria on the skin surface to prevent surgical site infections. The product is indicated for general bacterial control and is widely used in perioperative settings.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), commercial teams should expect portfolio rationalization and transition planning toward post-LOE support roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
With 571 linked jobs, CHLORAPREP TRIPLE SWABSTICK support spans manufacturing operations, field sales, and clinical education—reflecting a mature, high-volume product generating substantial operational and commercial employment. Roles skew heavily toward field execution (Territory Managers, Clinical Specialists) and operations (Manufacturing, Engineering), indicating a stable but not growth-trajectory career experience.
Worked on CHLORAPREP TRIPLE SWABSTICK at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.